BKYI NASDAQ
BIO-key International, Inc.
1W: +18.4%
1M: -27.6%
3M: -48.4%
YTD: -64.1%
1Y: -72.7%
3Y: -97.8%
5Y: -99.7%
$2.12
-0.17 (-7.42%)
Weekly Expected Move ±47.2%
$0
$1
$2
$3
$4
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Supply Chain
Revenue Segmentation
By Product / Service
By Geography
Revenue by Segment (5-Year Trend)
Income Trends
Revenue
$6M
-12.0% ▼
5Y CAGR: +16.5%
Gross Profit
$5M
-16.3% ▼
5Y CAGR: +18.3%
Operating Income
-$4M
-6.2% ▼
Net Income
-$5M
-6.7% ▼
EPS (Diluted)
$-0.69
+37.8% ▲
EBITDA
-$4M
-20.1% ▼
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | $5M | $7M | $8M | $7M | $6M |
| YoY Growth | +80.3% | +37.3% | +10.5% | -10.6% | -12.0% |
| Cost of Revenue | $2M | $2M | $6M | $1M | $1M |
| Gross Profit | $3M | $5M | $1M | $6M | $5M |
| Gross Margin | 67.3% | 65.2% | 18.5% | 81.4% | 77.5% |
| R&D Expenses | $2M | $3M | $2M | $3M | $3M |
| SG&A Expenses | $6M | $9M | $8M | $7M | $6M |
| Operating Expenses | $8M | $15M | $10M | $10M | $9M |
| Operating Income | -$5M | -$10M | -$9M | -$4M | -$4M |
| Operating Margin | -96.6% | -141.4% | -113.8% | -57.9% | -69.9% |
| Interest Expense | $18K | $10K | $218K | $300K | -$61K |
| Income Before Tax | -$5M | -$12M | -$9M | -$4M | -$5M |
| Tax Expense | $0 | -$20K | -$134K | -$23K | -$16K |
| Net Income | -$5M | -$12M | -$9M | -$4M | -$5M |
| Net Margin | -99.0% | -169.7% | -109.9% | -62.1% | -75.3% |
| EPS (Diluted) | $-11.70 | $-26.46 | $-15.21 | $-1.11 | $-0.69 |
| EBITDA | -$5M | -$11M | -$8M | -$4M | -$4M |
| Shares Outstanding | 432874 | 450043 | 560278 | 4M | 7M |